When to Use Targeted Therapy for the Treatment of Follicular Lymphoma

被引:0
|
作者
Loretta J. Nastoupil
机构
[1] UT MD Anderson Cancer Center,Department of Lymphoma/Myeloma
来源
Current Hematologic Malignancy Reports | 2021年 / 16卷
关键词
Follicular lymphoma; Targeted therapy; Lenalidomide; Tazemetostat;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:45 / 51
页数:6
相关论文
共 50 条
  • [1] When to Use Targeted Therapy for the Treatment of Follicular Lymphoma
    Nastoupil, Loretta J.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (01) : 45 - 51
  • [2] Targeted Treatment of Follicular Lymphoma
    Nath, Karthik
    Gandhi, Maher K.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (02): : 1 - 22
  • [3] Targeted treatment and new agents in follicular lymphoma
    Bruce D. Cheson
    International Journal of Hematology, 2010, 92 : 5 - 11
  • [4] Targeted treatment and new agents in follicular lymphoma
    Cheson, Bruce D.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (01) : 5 - 11
  • [5] Targeted Therapy in Follicular Lymphoma: Towards a Chemotherapy-Free Approach
    Chen, Chung-Jiah J.
    Choi, Michael Y.
    Heyman, Benjamin M.
    CANCERS, 2023, 15 (18)
  • [6] Follicular lymphoma: Management options in the era of targeted therapy
    Peterson C.G.
    Kahl B.S.
    Current Treatment Options in Oncology, 2005, 6 (4) : 297 - 308
  • [7] Targeted Therapy for Relapsed/Refractory Follicular Lymphoma: Focus on Clinical Utility of Tazemetostat
    Raychaudhuri, Ruben
    Ujjani, Chaitra
    ONCOTARGETS AND THERAPY, 2022, 15 : 193 - 199
  • [8] Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab
    Lopedote, Paolo
    Shadman, Mazyar
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 257 - 264
  • [9] Biology and treatment of follicular lymphoma
    Piccaluga, Pier Paolo
    Sapienza, Maria Rosaria
    Agostinelli, Claudio
    Sagramoso, Carlo
    Mannu, Claudia
    Sabattini, Elena
    Zinzani, Pier Luigi
    Pileri, Stefano A.
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (05) : 533 - 547
  • [10] THE USE OF MYELOABLATIVE THERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN THE TREATMENT OF FOLLICULAR LYMPHOMA
    JOHNSON, PWM
    ROHATINER, AZS
    LEUKEMIA & LYMPHOMA, 1992, 6 (4-5) : 299 - 304